[{"Assets_0_Q3_USD":"19953380000.0","CIK":"12208","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"131.75","EarningsPerShareBasic_3_Q3_USD":"195.29","EarningsPerShareDiluted_1_Q3_USD":"129.96","EarningsPerShareDiluted_3_Q3_USD":"192.76","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","Market Cap":"16656203893.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"498597000.0","NetIncomeLoss_1_Q3_USD":"3928033000.0","NetIncomeLoss_3_Q3_USD":"5819561000.0","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","RevenuesConverted_1_Q3_USD":"747049000.0","RevenuesConverted_3_Q3_USD":"2189776000.0","SP500":"SP500","Sector":"Capital Goods","StockholdersEquity_0_Q3_USD":"15332378000.0","Ticker":"BIO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"30224000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"30190000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"29814000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"29800000.0","filed":"20211029","footnote":null,"form":"10-Q","fp":"Q3","fy":"2021.0","name":"BIO-RAD LABORATORIES, INC.","period":"20210930","qtrs":"0","uom":"USD"}]